# Discriminator report

## Scenario echo
The scenario is human pancreas with no specified age, sex, disease, treatment, or narrowed cell type, so the embedding should cover the baseline human pancreatic cell-type landscape across endocrine, exocrine, ductal, stromal, vascular, neural/glial, and resident immune compartments. There are no notes imposing a special topology or emphasis.

## Rating: minor
The blueprint covers the major human pancreas compartments and has a plausible gated structure for endocrine and immune subtypes. It still needs targeted refinement for a few expected subcompartments and for one contrast-axis design that conflates adjacent vascular/stromal lineages rather than resolving them.

## Findings

### Minor issues
- **pericyte_smooth_muscle module / pericyte_smooth_muscle_vs_endothelium axis** — Pericytes and vascular smooth muscle cells are merged into one mural module and then contrasted against endothelial cells. These are neighboring vascular support lineages, not a clean opposing biological program, and the combined marker set mixes pericyte markers (RGS5, PDGFRB, CSPG4, MCAM, NOTCH3) with smooth muscle/myofibroblast markers (ACTA2, MYH11, TAGLN). This loses resolution for an expected human pancreas stromal/vascular compartment.
  *Fix:* Split mural support into a pericyte axis/module and a vascular smooth muscle axis/module, or at minimum change the existing contrast axis into a plain mural-support axis and add a separate smooth muscle/contractile vessel-wall axis. Keep endothelial and mural programs as separate axes rather than an endothelial-vs-mural contrast.
- **ductal/epithelial coverage** — The ductal compartment is represented by general ductal, ion-transport, and centroacinar-like modules, but it does not separately capture common stress/regenerative ductal or acinar-to-ductal/reactive epithelial programs that often appear in human pancreas single-cell data even outside overt disease. Current centroacinar markers (MMP7, SPP1, CLU, ANXA4) partly overlap this biology, but the axis is framed as centroacinar rather than a reactive ductal/ADM-like state.
  *Fix:* Either rename/refocus the centroacinar axis as a reactive/centroacinar ductal state with a clearer marker set, or add a scoped reactive epithelial/ductal-state axis using canonical genes such as CLU, SPP1, KRT19, MMP7, REG-family or stress/acute-phase markers if supported by the cited pancreas literature.
- **granulocyte coverage** — The leukocyte tree resolves macrophage/monocyte, dendritic/APC, mast, T, NK, B, and plasma cells, but lacks a neutrophil/granulocyte axis. Granulocytes are not a dominant healthy pancreas population, but they can be present in human pancreas atlases or tissue suspensions and are a biologically expected immune contaminant/resident inflammatory compartment.
  *Fix:* Add a neutrophil/granulocyte module and gated leukocyte axis if the literature resources used by the blueprint support it, with markers such as S100A8, S100A9, FCGR3B, CXCR2, CSF3R, MNDA, LST1, and/or NAMPT chosen carefully to avoid excessive monocyte overlap.
- **epsilon_cell module** — The epsilon-cell axis is useful, but the marker set is thin and includes MLN, which is more characteristic of intestinal/enteroendocrine programs than a canonical adult pancreatic epsilon identity. This is not fatal because GHRL is present, but a domain expert may question the specificity.
  *Fix:* Tighten the epsilon module around pancreas-supported ghrelin-cell markers and remove or replace MLN unless the cited pancreas sources explicitly support it for human pancreatic epsilon cells.

## Out of scope (FYI, not actionable for the Generator)
- I did not verify DOIs or citation-title matches; that is outside this discriminator scope.

## Summary for the next round
The next Generator should keep the overall compartment structure, but improve vascular/stromal resolution by separating pericyte and smooth muscle rather than contrasting mural cells against endothelium, clarify reactive/centroacinar ductal-state handling, consider a leukocyte-gated neutrophil/granulocyte axis, and tighten the epsilon-cell markers.
